U.S. flag

An official website of the United States government

NM_002294.3(LAMP2):c.472A>G (p.Thr158Ala) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jul 6, 2012
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000037419.5

Allele description [Variation Report for NM_002294.3(LAMP2):c.472A>G (p.Thr158Ala)]

NM_002294.3(LAMP2):c.472A>G (p.Thr158Ala)

Gene:
LAMP2:lysosomal associated membrane protein 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq24
Genomic location:
Preferred name:
NM_002294.3(LAMP2):c.472A>G (p.Thr158Ala)
HGVS:
  • NC_000023.11:g.120449054T>C
  • NG_007995.1:g.25296A>G
  • NM_001122606.1:c.472A>G
  • NM_002294.3:c.472A>GMANE SELECT
  • NM_013995.2:c.472A>G
  • NP_001116078.1:p.Thr158Ala
  • NP_002285.1:p.Thr158Ala
  • NP_002285.1:p.Thr158Ala
  • NP_054701.1:p.Thr158Ala
  • LRG_749t1:c.472A>G
  • LRG_749t2:c.472A>G
  • LRG_749t3:c.472A>G
  • LRG_749:g.25296A>G
  • LRG_749p1:p.Thr158Ala
  • LRG_749p2:p.Thr158Ala
  • LRG_749p3:p.Thr158Ala
  • NC_000023.10:g.119582909T>C
  • NM_002294.2:c.472A>G
  • c.472A>G
Protein change:
T158A
Links:
dbSNP: rs138374063
NCBI 1000 Genomes Browser:
rs138374063
Molecular consequence:
  • NM_001122606.1:c.472A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002294.3:c.472A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_013995.2:c.472A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000061076Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Uncertain significance
(Jul 6, 2012)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot provided11not providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000061076.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Variant classified as Uncertain Significance - Favor Benign. The Thr158Ala varia nt in LAMP2 has been identified in 2/6727 European American chromosomes from a b road population by the NHLBI Exome Sequencing Project (http://evs.gs.washington. edu/EVS; dbSNP rs138374063). Threonine (Thr) at position 158 is not conserved in mammals or evolutionarily distant species and elephant carries an alanine (Ala; this variant), suggesting that this change may be tolerated. In addition, compu tational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) suggest that this variant may not impact the protein, though this informat ion is not predictive enough to rule out pathogenicity. In summary, the frequenc y of this variant and lack of amino acid conservation suggests that it may be mo re likely benign, but additional information is needed to fully assess its clini cal significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot provided1not provided1not provided

Last Updated: Sep 29, 2024